Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Maria Queralt Salas Gay, MD, Santiago Mercadal, MD, Eva Domingo Domenech, MD, Ana C Oliveira, MD PhD, Maite Encuentra, Fina Climent, MD PhD, Cristina Baca Cano, MD, Marcio Andrade-Campos, MD PhD, Esmeralda De la Banda, MD, Carmen Aguilera, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, Eva González-Barca, MD PhD

Blood (2017) 130 (Supplement 1): 4151.

https://doi.org/10.1182/blood.V130.Suppl_1.4151.4151

Published: 2017

Journal Articles

Abnormal Karyotype (Not Only Complex) at Diagnosis Is an Independent Prognostic Factor for Overall Survival in Early Stage Chronic Lymphocytic Leukemia Patients. Results of a Prospective Study with a Median Follow-up of More Than 7-Years

Ana C Oliveira, MD PhD, Esmeralda De la Banda, MD, Eva Domingo Domenech, MD, Isabel Granada, PhD, Alberto Fernandez de Sevilla, MD PhD, Santiago Mercadal, MD, Marcio Andrade-Campos, MD PhD, Maite Encuentra, Carmen Aguilera, Anna Sureda, Eva González-Barca, MD PhD

Blood (2017) 130 (Supplement 1): 5142.

https://doi.org/10.1182/blood.V130.Suppl_1.5142.5142

Published: 2017

Journal Articles

CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like

Maria Queralt Salas, MD, Fina Climent, PhD, Eva Domingo Domenech, MD, Santiago Mercadal, MD, Viviana Paredes, MD, Ana Carla Oliveira, PhD, Carmen Aguilera, Mrs, Esmeralda de la Banda, MD, Anna Lucas, MD, Nadia Garcia, MD, Cristina Baca, MD, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, MD PhD, Eva Gonzalez Barca, PhD, Maria Lutgarda Riasol

Blood (2016) 128 (22): 4209.

https://doi.org/10.1182/blood.V128.22.4209.4209

Published: 2016

Journal Articles

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Jose Tomas Navarro, MD; PhD, Maria Rozman, MD, PhD, Leonor Arenillas, Ana Aventin, Teresa Gimenez, MD, Esther Alonso, MD, PhD, Granada Perea, MD; PhD, Mireia Camós, MD, PhD, Mayda Navarrete, MD, Esperanza Tuset, MD, Lourdes Florensa, MD, Fuensanta Millá, MD, PhD, Josep F Nomdedeu, MD, Esmeralda de la Banda, MD, Marina Díaz-Beyá, MD, Salut Brunet, Jorge Sierra, MD, PhD, Jordi Esteve, MD, PhD

Blood (2012) 120 (21): 2551.

https://doi.org/10.1182/blood.V120.21.2551.2551

Published: 2012

Journal Articles

Akt Inhibitors Induce Apoptosis in Chronic Lymphocytic Leukemia Cells.

Mercè de Frias, Daniel Iglesias-Serret, PhD, Ana M Cosialls, Llorenç Coll-Mulet, PhD, Antonio F Santidrián, PhD, Diana M González-Gironès, Esmeralda de la Banda, MD, Alberto Fernandez de Sevilla, MD, PhD, Gabriel Pons, MD, PhD, Joan Gil, PhD

Blood (2009) 114 (22): 1731.

https://doi.org/10.1182/blood.V114.22.1731.1731

Published: 2009

Journal Articles

Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL). Results of a Single Center.

Josep Sarra, Esmeralda de la Banda, MD, Encuentra Maite, Jose Petit, Eva Gonzalez-Barca, Eva Domingo-Domènech, MD, Ana Carla Oliveira, Santiago Mercadal, MD, Victoria Clapes, Alberto Fernandez de Sevilla, MD, PhD

Blood (2009) 114 (22): 4108.

https://doi.org/10.1182/blood.V114.22.4108.4108

Published: 2009

NARROW

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Abnormal Karyotype (Not Only Complex) at Diagnosis Is an Independent Prognostic Factor for Overall Survival in Early Stage Chronic Lymphocytic Leukemia Patients. Results of a Prospective Study with a Median Follow-up of More Than 7-Years

CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Akt Inhibitors Induce Apoptosis in Chronic Lymphocytic Leukemia Cells.

Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL). Results of a Single Center.

Email alerts

ASH Publications

American Society of Hematology

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Abnormal Karyotype (Not Only Complex) at Diagnosis Is an Independent Prognostic Factor for Overall Survival in Early Stage Chronic Lymphocytic Leukemia Patients. Results of a Prospective Study with a Median Follow-up of More Than 7-Years

CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Akt Inhibitors Induce Apoptosis in Chronic Lymphocytic Leukemia Cells.

Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL). Results of a Single Center.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only